Home › Funds › Aisling Capital Management LP › MRKR

Aisling Capital Management LP position in MRKR

MARKER THERAPEUTICS INC · Health Care

Aisling Capital Management LP reported holding 325,370 shares of MRKR (MARKER THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$348K, representing 0.12% of its reported portfolio and ranking #13 among its reported holdings. Aisling Capital Management LP has disclosed MRKR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)325.37K sh
Reported value held$348.15K
Portfolio Weight0.12%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Aisling Capital Management LP's MRKR position evolved

Aisling Capital Management LP first disclosed a stake in MRKR in Q3 2023 at 314,286 shares (US$1.4M). The position peaked in Q4 2023 at 314,286 shares, worth US$1.7M. Across 13 filings, Aisling Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 325,370 shares valued at US$348K.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 314.29K $1.43M New
Q4 2023 314.29K $1.73M Hold
Q1 2024 314.29K $1.35M Hold
Q2 2024 314.29K $1.71M Hold
Q3 2024 314.29K $886.29K Hold
Q4 2024 325.37K $1.01M Add
Q1 2025 325.37K $400.20K Hold
Q2 2025 325.37K $497.82K Hold
Q3 2025 325.37K $290.43K Hold
Q4 2025 325.37K $484.80K Hold
Q1 2026 325.37K $422.98K Hold
Q2 2026 325.37K $478.29K Hold
Q3 2026 325.37K $348.15K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRKR and 13F data

MRKR (MARKER THERAPEUTICS INC) is a Health Care company. 23 other funds we track also report a position in MRKR — the largest reported positions include NEA Management Company, LLC (US$2.4M), Blue Owl Capital Holdings LP (US$593K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRKR

All MRKR fund holders →

FAQ

How long has Aisling Capital Management LP held MRKR?

Aisling Capital Management LP has disclosed MRKR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Aisling Capital Management LP's current position in MRKR?

As of Q3 2026, Aisling Capital Management LP holds 325.37K shares of MRKR (MARKER THERAPEUTICS INC), valued at $348.15K, representing 0.12% of its reported portfolio and ranking #13.

Has Aisling Capital Management LP been buying or selling MRKR?

In the latest 13F filing (Q3 2026), Aisling Capital Management LP held unchanged its position in MRKR. The position peaked in Q4 2023 at 314.29K shares.

Which other funds hold MRKR?

Other major institutional holders of MRKR include NEA Management Company, LLC, Blue Owl Capital Holdings LP, among 23 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.